The global academic hepatology capacity index (IGCAH): a multi-source assessment reveals profound inequities across Latin America [0.03%]
全球学术肝病能力指数（IGCAH）：多源评估揭示拉丁美洲的深刻不平等现象
Pablo Coste,Ezequiel Ridruejo,Luis Antonio Díaz et al.
Pablo Coste et al.
Introduction and objectives: Academic hepatology capacity in Latin America is highly heterogeneous, yet no standardized regional framework exists to quantify structural differences across countries. We aimed to develop an...
Making metabolic dysfunction-associated steatotic liver disease medicines affordable: Lessons from hepatitis C [0.03%]
让与代谢功能障碍相关的脂肪性肝病药物可负担得起：丙型肝炎的启示
Khalid M AlNaamani,Mohamed El-Kassas,Zobair M Younossi
Khalid M AlNaamani
Cirrhotic cardiomyopathy impact goes global! The South American experience [0.03%]
肝硬化性心肌病的影响遍布全球！南美的经验
Murray Coetzee,Manhal Izzy
Murray Coetzee
Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B [0.03%]
长期抗病毒治疗可降低HBsAg水平、提高HBV RNA阴性率并改善慢性乙型肝炎患者的功能治愈比例
Ruihan Gao,Shuting Liu,Shiyu Zhang et al.
Ruihan Gao et al.
Sarcopenia risk in liver transplant candidates: Should artificial intelligence-based body composition analysis be incorporated into pre-transplant assessment? [0.03%]
肝移植候选人的 sarcopenia 风险：基于人工智能的体成分分析应纳入术前评估吗？
Jianhao Zhang,Zipei Wang,Guobin Huang et al.
Jianhao Zhang et al.
Marina Berenguer,Edna Ripollés,Ariadna Bono et al.
Marina Berenguer et al.
Introduction and objectives: Wilson disease is a rare autosomal recessive disorder caused by copper accumulation, primarily affecting the liver and brain. While genetic estimates suggest a global prevalence of 13.9-15.4 p...
Nationwide analysis on the impact of the organization of care on the outcomes of perihilar cholangiocarcinoma [0.03%]
全国范围的分析：护理组织对肝门胆管癌结局影响的研究
Merve Rousian,Julien A Luyten,Lydia van der Geest et al.
Merve Rousian et al.
Introduction and objectives: Perihilar cholangiocarcinoma (pCCA) is a rare and complex liver malignancy requiring specialized care in academic centers and multidisciplinary teams (MDTs). This study aimed to evaluate the i...
The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens [0.03%]
AMAGE指南：从地区角度看与代谢紊乱相关脂肪性肝病
Said A Al-Busafi,Mohammed Eslam
Said A Al-Busafi
Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis [0.03%]
非选择性β受体阻滞剂与肝硬化患者肝细胞癌发生风险的相关性：一项荟萃分析
Yan Xu,Xiaohe Wang,Xiangdong Li et al.
Yan Xu et al.
Introduction and objectives: Nonselective β blockers (NSBBs) may be involved in reducing gut-derived inflammation and intrahepatic inflammation to prevent hepatocellular carcinoma (HCC). This study aimed to systematicall...